首页> 外国专利> ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY OF AN ACUTE DISEASE OR ACUTE CONDITION OF A PATIENT FOR STABILIZING THE CIRCULATION

ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY OF AN ACUTE DISEASE OR ACUTE CONDITION OF A PATIENT FOR STABILIZING THE CIRCULATION

机译:抗肾上腺素(ADM)抗体或抗ADM抗体片段或抗ADM非IG支架,用于治疗患者的急性疾病或急性病以稳定循环

摘要

Patients having a chronic or acute disease or acute condition may be in need for stabilizing the circulation. Subject matter of the present invention is an anti-Adrenomedullin (ADM) antibody or an anti-adrenomedullin antibody fragment or an anti-ADM non-Ig scaffold for use in therapy of acute disease or condition of a patient for stabilizing the circulation. In a preferred embodiment anti-ADM antibody or an anti-adrenomedullin antibody fragment or an anti-ADM non-Ig scaffold according to the present invention reduces the vasopressor requirement, e.g. catecholamine requirement of said patient. The catecholamine requirement of a patient is an indicator for the condition of the circulation and hemodynamic function of said patient.
机译:患有慢性或急性疾病或急性疾病的患者可能需要稳定血液循环。本发明的主题是抗肾上腺髓质素(ADM)抗体或抗肾上腺髓质素抗体片段或抗ADM非Ig支架,用于治疗急性疾病或患者病情以稳定循环。在一个优选的实施方案中,根据本发明的抗ADM抗体或抗肾上腺髓质素抗体片段或抗ADM非Ig支架降低了血管加压剂的需求,例如降低了抗血管生成素的量。所述患者的儿茶酚胺需求量。患者的儿茶酚胺需求量是所述患者的循环状况和血液动力学功能的指标。

著录项

  • 公开/公告号LT2780370T

    专利类型

  • 公开/公告日2019-11-25

    原文格式PDF

  • 申请/专利权人 ADRENOMED AG;

    申请/专利号LT12784632T

  • 发明设计人 BERGMANN ANDREAS;

    申请日2012-11-16

  • 分类号C07K16/26;A61K39/395;A61P9;A61P13/12;A61P31;

  • 国家 LT

  • 入库时间 2022-08-21 11:17:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号